Huajin Pharma has a registered capital of RMB 6 millions, total assets of RMB 21 millions and more than 100 employees. 60% of the employees are professional staffs in pharmacy, medical, and chemical engineering etc. Up to now, Huajin Pharma has gained 5 patents, such as the Preparation Method of Hepatocyte Growth-Promoting Factors Enteric-Coated Capsules and the Preparation Method of Human Placenta RNA for Injection etc.
Our main products are Hepatocyte Growth-Promoting Factors Enteric-Coated Capsules, Transfer Factors Capsules, Pearl Powder Capsules and many biological raw materials, like Cerebroprotein hydrolysate(Cerebrolysin concentrate), Hepatocyte Growth-Promoting Factors, Transfer Factors, Thymomodulin, Thymopentin, Vidarabine etc.
Company Profile
-
Established in1996
-
Business types
- ODM Manufacturer
- Exporter/Agent
-
Markets
-
North America / South America / Caribbean / West Europe / East Europe / Russia / East Asia / Southeast Asia / Mid-East / Africa / Australia / New Zealand / China / Hong Kong